BACKGROUND An estimated 350 adults develop severe, but potentially reversible respiratory failure in the UK annually. Current management uses intermittent positive pressure ventilation, but barotrauma, volutrauma and oxygen toxicity can prevent lung recovery. An alternative treatment, extracorporeal membrane oxygenation, uses cardio-pulmonary bypass technology to temporarily provide gas exchang...

OBJECTIVE The development of the extracorporeal membrane oxygenation in Latin America represents a challenge in this specialty field. The objective of this article was to describe the results of a new extracorporeal membrane oxygenation program in an intensive care unit. METHODS This retrospective cohort study included 22 patients who required extracorporeal membrane oxygenation and were trea...

BACKGROUND Limited data are available describing the clinical presentation and risk factors for admission to the intensive care unit for children with 2009 H1N1 infection. METHODS We conducted a retrospective chart review of all hospitalized children with 2009 influenza A (H1N1) and 2008-09 seasonal influenza at The Children's Hospital, Denver, Colorado. RESULTS Of the 307 children identifi...

We present the first report in the literature of a child with human metapneumovirus pneumonia who required extracorporeal membrane oxygenation for survival. This was a 3-month-old premature boy from British Columbia, Canada, who developed severe respiratory failure, experienced failure of high-frequency oscillatory mechanical ventilation, and required extracorporeal membrane oxygenation support...

Extracorporeal membrane oxygenation is used in refractory hypoxemia in many clinical settings. Thoracic trauma patients usually develop acute respiratory distress syndrome. Due to high risk of bleeding, thrombotic complications present in this context are particularly difficult to manage and usually require insertion of an inferior vena cava filter to prevent embolism from the distal veins to t...

Up to one third of patients with influenza A (H1N1) virus require intensive care unit (ICU) admission because of severe pneumonia, sepsis, or acute respiratory distress syndrome or a combination of these. Still, inICU mortality rate remains excessively high despite the deployment of maximal therapeutic support, often including extracorporeal membrane oxygenation [1]. In this perspective, the re...

Introduction: Extracorporeal membrane oxygenation (ECMO) is a support therapy that can be used in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and refractory hypoxemia, despite optimal management. However, ECMO may responsible for synergic effect the proposed mechanism of viral associated hyperinflammation.